Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
A quick evaluation of altcoin teams in 2024, focusing on development cadence, leadership experience, and past deliverables.
27,475 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
XRPL posted the strongest 90-day RWAs inflow among major blockchains, narrowly topping Ethereum and Solana. Analysts ...
AppLovin is rebounding as AI ad-tech momentum returns, with analysts modeling upside to $600+ as AXON 2 expands and b...
CoStar Group stockholders reaffirm board support at Tuesday's annual meeting, backing eight directors and an updated ...
A surge in U.S. retirees moving to Pacific coast towns in Mexico is reshaping retirement plans. Costs, visas, and cur...
A divorced listener earning about $100,000 was advised to liquidate home equity to wipe out debt, a move that reignit...
As the 2026 World Cup nears its end, FIFA President Gianni Infantino logged a remarkable travel footprint on a privat...
Reese Witherspoon tells a Gen Z follower to chase talents, not dreams, in a viral moment. The message lands amid a 20...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Costco reported a sturdy quarterly performance, signaling continued strength in its membership model. The company spo...
An accidental mass email turns a shy campus newcomer into a social-media sensation and a thriving pet-sitting busines...
A leading AI investor says up to 80% of jobs could be AI-enabled by 2030, a view that’s fueling a new wave of policy ...